India consults media on national biotechnology authority
The Indian government’s Department of Biotechnology (DBT) held a consultation with senior representatives of the news media on June 28th on a proposed national biotechnology regulatory bill. The representatives discussed several aspects of the proposed bill including: data exclusivity; sharing of information on field trials and safety testing with the public; and ensuring full autonomy to the proposed regulatory authority. The DBT recently came up with a draft plan for the setting up of the National Biotechnology Regulatory Authority as an independent, autonomous and professionally-led body providing a single window mechanism for biosafety clearance of genetically modified products and processes ( Agrow No 545, p 21). The draft was open to public comments until June 22nd.